Stock Scorer

agilon health, inc. (AGL)

agilon health, inc. reported revenue of 1.5B USD for the quarter ending 30 June 2026, up 7.2% from 1.4B a year earlier.

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than filled in. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD. The same series drawn ›

As last reported

The newest period the filing supports for each figure, in USD.
FigurePeriodAmountYear on year
Revenue Q2 '26 · ending 30 June 2026 1.5B +7.2%
Operating Income Q2 '26 · ending 30 June 2026 11.8M —
Net Income Q2 '26 · ending 30 June 2026 18M —
Operating Cash Flow Q2 '26 · ending 30 June 2026 -57.3M —
Free Cash Flow Q2 '26 · ending 30 June 2026 -60.7M —
Shares Outstanding Q2 '26 · ending 30 June 2026 17.2M +4.2%

Revenue and profit by financial year

As filed, in USD. A year the filing does not support is not listed.
YearEnding RevenueOperating IncomeNet IncomeFree Cash Flow
20252025-12-31 5.9B-463.2M-391.3M-119M
20242024-12-31 6.1B-292.1M-260.2M-71M
20232023-12-31 4.3B-232.1M-262.6M-172M
20222022-12-31 2.4B-105.4M-106.6M-146.2M
20212021-12-31 1.5B-372.2M-406.5M-154.7M
20202020-12-31 1.2B-56.7M-60.1M-55M
20192019-12-31 794.4M-106.6M-282.6M-106.8M

Every period

Revenue Quarterly

PeriodEndingRevenue
Q2 '262026-06-301.5B
Q1 '262026-03-311.4B
Q4 '252025-12-311.6B
Q3 '252025-09-301.4B
Q2 '252025-06-301.4B
Q1 '252025-03-311.5B
Q4 '242024-12-311.5B
Q3 '242024-09-301.5B
Q2 '242024-06-301.5B
Q1 '242024-03-311.6B
Q4 '232023-12-311.1B
Q3 '232023-09-301.1B
Q2 '232023-06-301.1B
Q1 '232023-03-311.1B
Q4 '222022-12-31369.8M
Q3 '222022-09-30694.9M
Q2 '222022-06-30670.1M
Q1 '222022-03-31653.4M
Q4 '212021-12-31150.8M
Q3 '212021-09-30458.6M

Operating Income Quarterly

PeriodEndingOperating Income
Q2 '262026-06-3011.8M
Q1 '262026-03-314M
Q4 '252025-12-31-193.8M
Q3 '252025-09-30-131.3M
Q2 '252025-06-30-116M
Q1 '252025-03-31-22.1M
Q4 '242024-12-31-108.1M
Q3 '242024-09-30-133.5M
Q2 '242024-06-30-43.3M
Q1 '242024-03-31-7.2M
Q4 '232023-12-31-164.3M
Q3 '232023-09-30-39.3M
Q2 '232023-06-30-29M
Q1 '232023-03-31417K
Q4 '222022-12-31-54.1M
Q3 '222022-09-30-29.5M
Q2 '222022-06-30-21.1M
Q1 '222022-03-31-743K
Q4 '212021-12-31-26.2M
Q3 '212021-09-30-35.6M

Net Income Quarterly

PeriodEndingNet Income
Q2 '262026-06-3018M
Q1 '262026-03-3148.9M
Q4 '252025-12-31-188.9M
Q3 '252025-09-30-110.2M
Q2 '252025-06-30-104.4M
Q1 '252025-03-3112.1M
Q4 '242024-12-31-105.8M
Q3 '242024-09-30-117.6M
Q2 '242024-06-30-30.7M
Q1 '242024-03-31-6.1M
Q4 '232023-12-31-230.4M
Q3 '232023-09-30-31.4M
Q2 '232023-06-30-16.7M
Q1 '232023-03-3116M
Q4 '222022-12-31-56.5M
Q3 '222022-09-30-30.7M
Q2 '222022-06-30-20.6M
Q1 '222022-03-311.2M
Q4 '212021-12-31-56.7M
Q3 '212021-09-30-35.8M

Operating Cash Flow Quarterly

PeriodEndingOperating Cash Flow
Q2 '262026-06-30-57.3M
Q1 '262026-03-3123.7M
Q4 '252025-12-31-20.5M
Q3 '252025-09-30-18.2M
Q2 '252025-06-30-35.1M
Q1 '252025-03-31-32M
Q4 '242024-12-3116.4M
Q3 '242024-09-30-7.7M
Q2 '242024-06-30-18.7M
Q1 '242024-03-31-47.8M
Q4 '232023-12-31-61.2M
Q3 '232023-09-30-13M
Q2 '232023-06-30-21.2M
Q1 '232023-03-31-60.8M
Q4 '222022-12-31-50M
Q3 '222022-09-302.6M
Q2 '222022-06-30-60.3M
Q1 '222022-03-31-23.2M
Q4 '212021-12-31-48.9M
Q3 '212021-09-30-19.1M

Free Cash Flow Quarterly

Operating cash flow minus capital expenditure.

PeriodEndingFree Cash Flow
Q2 '262026-06-30-60.7M
Q1 '262026-03-3120.6M
Q4 '252025-12-31-23.5M
Q3 '252025-09-30-21.3M
Q2 '252025-06-30-38.3M
Q1 '252025-03-31-35.8M
Q4 '242024-12-3113.2M
Q3 '242024-09-30-11.2M
Q2 '242024-06-30-22M
Q1 '242024-03-31-50.9M
Q4 '232023-12-31-65.1M
Q3 '232023-09-30-17.1M
Q2 '232023-06-30-25.3M
Q1 '232023-03-31-64.5M
Q4 '222022-12-31-53.4M
Q3 '222022-09-30-786K
Q2 '222022-06-30-64.7M
Q1 '222022-03-31-27.3M
Q4 '212021-12-31-52.3M
Q3 '212021-09-30-21.7M

Shares Outstanding Quarterly

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

PeriodEndingShares Outstanding
Q2 '262026-06-3017.2M
Q1 '262026-03-3116.7M
Q3 '252025-09-30414.5M
Q2 '252025-06-3016.6M
Q1 '252025-03-3116.5M
Q3 '242024-09-30411.6M
Q2 '242024-06-30411.3M
Q1 '242024-03-31408.9M
Q3 '232023-09-30405.8M
Q2 '232023-06-30410.3M
Q1 '232023-03-31426.6M
Q3 '222022-09-30411.1M
Q2 '222022-06-30407.3M
Q1 '222022-03-31424.1M
Q3 '212021-09-30391.2M
Q2 '212021-06-30377.4M
Q1 '212021-03-31325.7M